National Institute of Allergy and Infectious Diseases; Amended Notice of Meeting
---
identifier: "/us/fr/2022-24060"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Institute of Allergy and Infectious Diseases; Amended Notice of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2022-24060"
section_name: "National Institute of Allergy and Infectious Diseases; Amended Notice of Meeting"
positive_law: false
currency: "2022-11-04"
last_updated: "2022-11-04"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2022-24060"
document_type: "notice"
publication_date: "2022-11-04"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "87 FR 66718"
fr_volume: 87
---
# National Institute of Allergy and Infectious Diseases; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National Institute of Allergy and Infectious Diseases Special Emphasis Panel NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) which was published in the *Federal Register* on October 28, 2022, FR Doc 2022-23540, 87 FR 65215.
Amendment to change meeting date and time from November 14, 2022, at 2:00 p.m. to 5:00 p.m. to November 15, 2022, at 1:00 p.m. to 4:00 p.m. The meeting is closed to the public.
Dated: November 1, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.